An immunoliposome preparation or an antibody modified with a hydrophobic molecule which has a therapeutic effect on cancer, an autoimmune disease or an inflammatory disease. Namely, an immunoliposome or an antibody modified with a hydrophobic molecule comprising an antibody, which can induce apoptosis into a cell expressing a death domain-containing receptor, as a constituting element thereof.
